Friday, April 20, 2018
 
 
Company News: Page (1) of 1 - 01/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer
 
(January 12, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords: Inc.,Medicine,medical technologists,Cancer,Surgery,Medication,Womens Health,Science,Lifestyle,Medical,Biology,Stem Cell,Cancer,Business,Science,
Related Sites: DMN Newswire ,   CEN - Consumer Electronics Net ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines